Human Recombinant IL-18 binding (from Cells)

Supplier: ProSci
PRSI91-814EA 235 EUR
PRSI91-814
Human Recombinant IL-18 binding (from Cells)
Proteins and Peptides
Interleukin-18-binding protein, also known as Tadekinig-alfa and IL18BP, contains 1 Ig-like C2-type domain. IL18BP is constitutively expressed and secreted in mononuclear cells. IL18BP functions as an IL18 inhibitor. IL18BP binds to IL18, prevents the binding of IL18 to its receptor, and thus inhibits IL18-induced IFN-gamma production. It has been shown that IL18BP may be a promising molecular approach to inhibit neointimal hyperplasia and arteriosclerosis progression following coronary and peripheral angioplasty.

  • This recombinant protein can be used for biological assays. For research use only.

Fusion-Tag: C-Fc tag
Order Now

Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Learn more About VWR